11 – 14 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2016
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
(
- Contribution to journal › Article
- 2014
-
Mark
TCF7L2 is a master regulator of insulin production and processing.
(
- Contribution to journal › Article
- 2005
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »